View in EDS

ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis.

Saved in:
Bibliographic Details
Title: ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis.
Authors: Zheng F; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.; The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine (F.Z., M.S., J.W.), Nanjing Medical University, China., Geng Z; Department of Cardiac Surgery, The Second Affiliated Hospital of Nanjing Medical University, China (Z.G., Q.L.)., Ye C; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, China (C.Y.)., Hao M; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China., Sha M; The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine (F.Z., M.S., J.W.), Nanjing Medical University, China., Shan H; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China., Zhou Y; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China., Jiang A; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China., Hou W; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China., Chen A; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China., Susan BD; Section of Vascular Biology & Inflammation, School of Cardiovascular and Metabolic Medicine & Sciences (South Bank), BHF Centre of Research Excellence, King's College London, United Kingdom (B.D.S.)., Wang J; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.; The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine (F.Z., M.S., J.W.), Nanjing Medical University, China., Li Q; Department of Cardiac Surgery, The Second Affiliated Hospital of Nanjing Medical University, China (Z.G., Q.L.)., Xiong X; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.
Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2026 May; Vol. 46 (5), pp. e324169. Date of Electronic Publication: 2026 Mar 05.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4636 (Electronic) Linking ISSN: 10795642 NLM ISO Abbreviation: Arterioscler Thromb Vasc Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41783930
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zheng+F%22">Zheng F</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.; The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine (F.Z., M.S., J.W.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Geng+Z%22">Geng Z</searchLink>; Department of Cardiac Surgery, The Second Affiliated Hospital of Nanjing Medical University, China (Z.G., Q.L.).<br /><searchLink fieldCode="AU" term="%22Ye+C%22">Ye C</searchLink>; Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, China (C.Y.).<br /><searchLink fieldCode="AU" term="%22Hao+M%22">Hao M</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Sha+M%22">Sha M</searchLink>; The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine (F.Z., M.S., J.W.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Shan+H%22">Shan H</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Zhou+Y%22">Zhou Y</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Jiang+A%22">Jiang A</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Hou+W%22">Hou W</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Chen+A%22">Chen A</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Susan+BD%22">Susan BD</searchLink>; Section of Vascular Biology & Inflammation, School of Cardiovascular and Metabolic Medicine & Sciences (South Bank), BHF Centre of Research Excellence, King's College London, United Kingdom (B.D.S.).<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.; The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine (F.Z., M.S., J.W.), Nanjing Medical University, China.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; Department of Cardiac Surgery, The Second Affiliated Hospital of Nanjing Medical University, China (Z.G., Q.L.).<br /><searchLink fieldCode="AU" term="%22Xiong+X%22">Xiong X</searchLink>; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C., J.W., X.X.), Nanjing Medical University, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229505803%22">Arteriosclerosis, thrombosis, and vascular biology</searchLink> [Arterioscler Thromb Vasc Biol] 2026 May; Vol. 46 (5), pp. e324169. <i>Date of Electronic Publication: </i>2026 Mar 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9505803 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1524-4636 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210795642%22">10795642 </searchLink><i>NLM ISO Abbreviation: </i>Arterioscler Thromb Vasc Biol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41783930
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1161/ATVBAHA.125.324169
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e324169
    Titles:
      – TitleFull: ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zheng F
      – PersonEntity:
          Name:
            NameFull: Geng Z
      – PersonEntity:
          Name:
            NameFull: Ye C
      – PersonEntity:
          Name:
            NameFull: Hao M
      – PersonEntity:
          Name:
            NameFull: Sha M
      – PersonEntity:
          Name:
            NameFull: Shan H
      – PersonEntity:
          Name:
            NameFull: Zhou Y
      – PersonEntity:
          Name:
            NameFull: Jiang A
      – PersonEntity:
          Name:
            NameFull: Hou W
      – PersonEntity:
          Name:
            NameFull: Chen A
      – PersonEntity:
          Name:
            NameFull: Susan BD
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Li Q
      – PersonEntity:
          Name:
            NameFull: Xiong X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1524-4636
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Arteriosclerosis, thrombosis, and vascular biology
              Type: main
ResultId 1